News|Podcasts|February 19, 2026

From Launch to Loss of Exclusivity: Reducing Access and Affordability Barriers Across the Brand Lifecycle

Author(s)CoverMyMeds

What you’ll learn:

  1. Discover how access barriers evolve across the biopharma brand lifecycle, from launch to loss of exclusivity, and how to address them proactively.
  2. Learn how data-driven insights and affordability solutions can help biopharma support providers and pharmacists at every stage.
  3. Understand the strategic role of lifecycle planning in improving medication access, reducing industry fragmentation and enhancing patient outcomes.


Related to this article

Pharmaceutical Executive Daily
FDA reportedly shelves its Commissioner’s National Priority Voucher program, Eli Lilly breaks ground on a $3.5 billion Pennsylvania manufacturing site for next-generation obesity treatments, and Parexel’s Stacy Hurt on how small protocol decisions can become enrollment and retention barriers.